Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: results from an Eastern Mediterranean populationEUROPEAN JOURNAL OF PUBLIC HEALTHIF3.92023-12-0910OAAI
THE INCLUSION OF THE UTILITY VALUES FOR CARERS AND FAMILY MEMBERS IN HTAS: A CASE STUDY OF RECENT NICE APPRAISALS IN THE UKVALUE IN HEALTHIF62019-05-011OAAI
Estimating a Preference-Based Single Index Measuring the Quality-of-Life Impact of Self-Management for DiabetesMEDICAL DECISION MAKINGIF2.32018-06-2915OAAI
Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes.VALUE IN HEALTHIF62018-01-0121OAAI
Developing a questionnaire to determine the impact of self-management in diabetes: giving people with diabetes a voiceHEALTH AND QUALITY OF LIFE OUTCOMESIF3.42017-07-1819OAAI
The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I DiabetesMEDICAL DECISION MAKINGIF2.32016-09-2746OAAI
The Capability Approach: A Critical Review of Its Application in Health EconomicsVALUE IN HEALTHIF62016-09-0128OAAI
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic modelHEALTH TECHNOLOGY ASSESSMENTIF42016-05-0131OA
The Economic Impact of Lower Protein Infant Formula for the Children of Overweight and Obese MothersNUTRIENTSIF52016-01-029OAAI
THE ECONOMIC IMPACT OF SHAPE FORMULA FOR THE CHILDREN OF OVERWEIGHT AND OBESE MOTHERSVALUE IN HEALTHIF62015-11-010OAAI
Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models: A Case Study in Type 1 DiabetesMEDICAL DECISION MAKINGIF2.32015-09-161OAAI
THE POTENTIAL VALUE OF ONGOING SUPPORT IN TYPE-1 DIABETES MELLITUS WITH DAFNEPLUS: EXPLORATORY PRE-TRIAL COST-EFFECTIVENESS ANALYSIS ON PROPOSED TRIAL END-POINT TARGET FOR 12-MONTH HBA1C IMPROVEMENTVALUE IN HEALTHIF62014-11-013OAAI
Assessing the cost-effectiveness of Type1 diabetes interventions: the Sheffield Type1 Diabetes Policy ModelDIABETIC MEDICINEIF3.42014-02-0527PREAI
A SYSTEMATIC REVIEW AND CRITICAL APRAISAL OF ECONOMIC EVALUATIONS OF RADIOTHERAPY FOR CANCERVALUE IN HEALTHIF62013-11-010OAAI
ECONOMIC EVIDENCE OF SURGICAL PROCEDURES IN CANCER: A SYSTEMATIC LITERATURE REVIEWVALUE IN HEALTHIF62013-11-010OAAI
The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy ModelDIABETIC MEDICINEIF3.42013-08-1938PREAI
Principles of health economic evaluations of lipid-lowering strategiesCURRENT OPINION IN LIPIDOLOGYIF4.62012-08-015PREAI